Saves heavy patients: New cure found from Kovida

Doctors, pharmacists and scientists have found a new medicine for coronavirus patients in severe form. This cocktail from antibodies does not save all, but many. The Russian BBC service writes that new – and quite expensive – the remedy is a mixture of two types of antibodies obtained in the laboratory, which is introduced intravenously and helps the body neutralize the virus.

Tests within the British Medicine Search Program from Covid Recovery Trial have shown that this tool helps each third of the hospitalized with the severe form of Kovida. Experts calculated that it saves six lives for each hundred past patients treated.

Medicine from monoclonal (cloned from one cell) Antibodies, which makes the American company Regenoron, costs from about 1,400 to 2,800 dollars. It is possible to treat them only those whose body himself did not work out antibodies that fight with coronavirus. In Britain, this medicine in the order of the experiment was given a thousand patients and found out that it significantly reduces the risk of death; stay in the hospital (on average for four days); The need for IVL apparatus.

One of the leaders of the tests Professor of Medicine and Epidemiology in Oxford University Sir Martin Landri says that a new tool reduces the risk of death among heavy patients about one-fifth.

The new remedy was used together with dexamethasone, anti-inflammatory steroid medicine. Doctors still a year ago found that dexamethasone in itself reduces the risk of death from Covid among heavy patients by about a third.

Medicine, which has passed tests under the Recovery Trial program, contains large doses of artificial, produced in the laboratory of antibodies that successfully associate coronavirus and do not affect the cells.